News and Media


Real-world studies confirm effectiveness of bulevirtide to treat chronic hepatitis D
March 20, 2023

Three articles published in the Journal of Hepatology and JHEP Reports demonstrate that bulevirtide is well tolerated and safe for treating chronic hepatitis delta, the most severe form of chronic viral hepatitis


Liver cirrhosis is associated with a lower immune response to COVID-19 vaccines but not with reduced vaccine efficacy
March 2, 2023

Results of a new study of patients with chronic liver disease, published in JHEP Reports show that age, cirrhosis and type of vaccine predict a “lower” immune response, while viral hepatitis etiology and prior antiviral therapy predict a “higher” immune response to two-dose COVID-19 mRNA vaccines

Advertisement